Kura Oncology
Stock Forecast, Prediction & Price Target
Kura Oncology (KURA) stock Price Target by analysts
$19
Potential upside: 159.20%
Kura Oncology price prediction
What is Kura Oncology stock analysts` prediction?
Kura Oncology stock forecast: Based on 2 Wall Street analysts` predicted price targets for Kura Oncology in the last 3 months, the avarage price target is $19, with a high forecast of $NaN. The average price target represents a 159.20% change from the last price of $7.33.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Kura Oncology stock Price Target by analysts
Full breakdown of analysts given Kura Oncology price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Bradley Canino Stifel Nicolaus | 0% 0/3 | 10 months ago | $11 50.06% upside | $10.8 | StreetInsider | Previous targets (2) |
David Dai UBS | 0% 0/1 | 11 months ago | $27 268.34% upside | $17.02 | StreetInsider | Previous targets (0) |
Bradley Canino Stifel Nicolaus | 0% 0/3 | 11 months ago | $19 159.20% upside | $18.58 | StreetInsider | Previous targets (2) |
Joseph Pantginis H.C. Wainwright | 0% 0/1 | about 1 year ago | $32 336.56% upside | $21.08 | StreetInsider | Previous targets (0) |
Bradley Canino Stifel Nicolaus | 0% 0/3 | over 1 year ago | $28 281.99% upside | $21.43 | StreetInsider | Previous targets (2) |
Mara Goldstein Mizuho Securities | 0% 0/1 | over 1 year ago | $26 254.70% upside | $13.81 | Benzinga | Previous targets (0) |
Kura Oncology Financial Estimates
Kura Oncology Revenue Estimates
Kura Oncology EBITDA Estimates
Kura Oncology Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $10.14M Low: $2.14M High: $22.62M avg. 0% | Avg: $99.07M Low: $92.06M High: $110.00M avg. 876.31% | Avg: $358.12M Low: $332.78M High: $397.61M avg. 261.46% | Avg: $422.81M Low: $392.90M High: $469.43M avg. 18.06% |
Net Income
% change YoY
| $-129.90M N/A | $-136.06M -4.74% | $-152.63M -12.17% | Avg: $-237.76M Low: $-216.75M High: $-148.65M avg. -55.78% | Avg: $-202.79M Low: $-260.69M High: $88.60M avg. 14.71% | Avg: $-31.94M Low: $-36.52M High: $-29.00M avg. 84.24% | Avg: $7.21M Low: $6.55M High: $8.25M avg. 122.59% |
EBITDA
% change YoY
| $-131.25M N/A | $-139.86M -6.55% | $-164.95M -17.93% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.96 N/A | -$2.03 -3.57% | -$2.08 -2.46% | Avg: -$2.63 Low: -$2.96 High: -$2.03 avg. -26.25% | Avg: -$2.11 Low: -$3.56 High: $1.21 avg. 19.50% | Avg: -$0.44 Low: -$0.5 High: -$0.4 avg. 79.36% | Avg: $0.1 Low: $0.09 High: $0.11 avg. 122.59% |
Operating Expenses
% change YoY
| $131.25M N/A | $139.86M 6.55% | $165.80M 18.54% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Kura Oncology stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 41.44% in 2025-2028.
We have gathered data from 11 analysts. Their low estimate is -216.75M, average is -237.76M and high is -148.65M.
What is Kura Oncology stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 288.96% in 2025-2028.
We have gathered data from 9 analysts. Their low revenue estimate is $2.14M, average is $10.14M and high is $22.62M.
What is Kura Oncology stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 48.80% in 2025-2028.
We have gathered data from 11 analysts. Their low earnings per share estimate is -$2.96, average is -$2.63 and high is $-2.03.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Kura Oncology stock. The most successful analyst is Bradley Canino.